Ultramicrosize Griseofulvin
- Product NDC
- 42794-014
- 11-digit product format
- 427940014
- Labeler code
- 42794
- Product ID
- 42794-014_d58d8124-4925-b8a1-e053-2995a90ac4c5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ultramicrosize Griseofulvin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Sigmapharm Laboratories, LLC
- Application
- ANDA202545
- Marketing category
- ANDA
- Marketing start
- 2012-11-15
- Substance
- GRISEOFULVIN
- Active strength
- 250 mg/1
- Pharmacologic classes
- Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ultramicrosize Griseofulvin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GRISEOFULVIN | 250 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 32HRV3E3D5 |
| Rxcui | 239239, 242831 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 42794-014-08 | Ultramicrosize Griseofulvin | 30 in 1 BOTTLE | TABLET | 30 | | 10 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42794-014 | ULTRAMICROSIZE GRISEOFULVIN TABLET [SIGMAPHARM LABORATORIES, LLC] | 10 | Current NDC, Legacy NDC, 1 package rows | 20220115_37b4d132-84f1-4394-b468-7e74eeec61eb.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42794-014-08 | 42794001408 | 30 TABLET in 1 BOTTLE (42794-014-08) | 30 tablet | 2016-05-11 | 0000-00-00 | No | No | Current |